×

Get the Prostate Cancer Patient Guide as a digital download or free mailed copy.

Click here.

Hsieh_Andrew(low)

Andrew C. Hsieh

Decades of research have revealed the cascade of signaling events that are in part responsible for the initiation and progression of cancer. These molecular pathways are mediated through complex array...Read More

Huihui from Google

Huihui Ye

There is no curative treatment available for high-risk, primary prostate cancer patients. Most of these tumors will initially respond to androgen deprivation therapy (ADT) but inevitably recur as a lethal...Read More

Kosj_Yamoah from Google

Kosj Yamoah

The risk of developing and dying from prostate cancer is higher in men of African descent. A genomic classifier test has been developed to identify men with prostate cancers that...Read More

Kamiesh Yadav

Kamlesh Yadav

Understanding the biology of how prostate cancer cells develop resistance to drugs, and how different drugs interact with one another will lead to the development of drug combinations that significantly...Read More

Wilson_Kathy(enh1)

Kathryn Wilson

Metastatic prostate cancer is essentially incurable and the most common metastatic site for prostate cancer is the bone. Understanding the interactions between prostate cancer cells and the bone environment will...Read More

Heemers_Hannelore(low)

Hannelore Heemers

Androgens (testosterone and related sex hormones) drive the growth and survival of prostate cancer. For almost seven decades, reducing androgens in patients with prostate cancer has been a widely utilized...Read More

Wang_Yu(enh1)

Yu Wang

Castrate-resistant prostate cancer (CRPC) is an aggressive, lethal form of prostate cancer that recurs after initial treatment with androgen deprivation therapy (ADT). ADT targets the androgen receptor (AR), the primary...Read More

Wang_Li

Li Wang

The identification of biomarkers to stratify risk for prostate cancer patients remains an unmet medical need. Dr. Li Wang is using bioinformatics methods to identify immune cell gene expression signatures...Read More

Hayes_Julia(low)

Julia Hayes

Prostate Specific Antigen (PSA) screening is widely used to assist the early diagnosis of prostate cancer. However, benefits of PSA screening are controversial. Dr. Hayes proposes to develop a model...Read More

Hamstra_Daniel(low)

Daniel Hamstra

The molecular processes that predict who will have a local recurrence after radiation therapy and who will not are not precisely understood. New evidence suggests that prostate tumors with abnormal...Read More